drugset / Trial / NCT00475904

A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)

NCT00475904

Phase 2 Completed 360 enrolled EpiCept Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare EpiCept™ NP-1 Topical Cream (2% ketamine / 4% amitriptyline) vs. Oral Gabapentin in the treatment of Postherpetic Neuralgia (PHN)

Timeline

Start
2007-07
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amitriptyline Small molecule 2 % Topical
Comparator Gabapentin Small molecule 1800 mg Oral
Comparator Ketamine Small molecule 4 % Topical